Azithromycin: can its benefit be ruled out in mild COVID-19?

Lancet Respir Med. 2021 Oct;9(10):1079-1081. doi: 10.1016/S2213-2600(21)00289-7. Epub 2021 Jul 9.
No abstract available

Publication types

  • Comment

MeSH terms

  • Azithromycin*
  • COVID-19 Drug Treatment*
  • Humans
  • SARS-CoV-2

Substances

  • Azithromycin